Boston Scientific Corporation (NYSE:BSX) soared 0.91% during previous trade, a total of 6.46M shares exchanged hands compared with its average trading volume of 7.77M shares whereas its relative volume is 0.76. The stock has a market capitalization of $30.41B along with 1.36B outstanding shares. Stock’s intraday price range hit the peak level of $22.10 and touched the lowest level of $21.78.
Most recently Boston Scientific Corporation (NYSE:BSX)’s price target was revised on 01/03/17 and according to 22 analysts stock’s price will reach at $27.66 during 52 weeks with standard deviation of 2.53. Stock’s minimum price target estimates has been figured out at $24 while the maximum price target forecast is established at $31, if we look at the price target with an optimistic approach it has upside potential of 42% from its latest closing price of $22.08.
Historically, if we look at price target revisions, three weeks ago Boston Scientific Corporation (NYSE:BSX)’s price target was revised on 11/15/16 by the analysts, however the bullish price estimates of the stock set at $30 while the bearish estimates kept at $19.50 over the next one year. Stock’s 52-week target was retained at $26.64, the estimates indicates a standard deviation of 2.53.
While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 1.57. ABR value is precisely based on brokerage recommendations, where out of 22 brokerage recommendations 14 rate Boston Scientific Corporation (NYSE:BSX) stock a Strong Buy, 3 rate the stocks of the company a Buy, 5 rate Hold, 0 rate Sell and 0 recommend a Strong Sell. Most recently on 9/1/2016 the stock of Boston Scientific Corporation (NYSE:BSX) upgraded by Argus from Hold to Buy. However previously on 10/5/15 it was upgraded by Raymond James from Outperform to Strong Buy. A research note issued on 9/28/15 the stock was upgraded by Needham from Hold to Buy.
Boston Scientific Corporation (NYSE:BSX) performance over the past one year soared 21.45% whereas its year to date (YTD) performance indicated a bullish trend of 2.08%. During the last six months the stock slipped -6.72%. Quarterly performance of the company shows declining momentum of -5.15% while its last one month trend is positive with 8.50%. Stock’s weekly performance expressed up trend of 1.47%.
The company’s price sits 3.05% above from its 50-day moving average of $21.17 and -0.86% away from the stock’s 200-day moving average which is $22.83. Boston Scientific Corporation (NYSE:BSX)’s shares are currently trading -10.93% away from the 52-week high price of $24.79 and +40.91% far from the 52-week low price of $15.67.
According to consensus agreement of 25 analysts Boston Scientific Corporation (NYSE:BSX) will report earnings per share of $0.29 in their quarterly report and it is expected to announce the company’s results on 2/2/17. For the current quarter the company has high EPS estimates of $0.3 in contradiction of low EPS estimates of $0.28. However a year ago for the same quarter the company has reported $0.26 EPS. Current year EPS projections for Boston Scientific Corporation (NYSE:BSX) set at $1.1 according to the sentiments of 27 analysts, while its lowest earnings estimates are $1.09 and highest earnings estimates are $1.12.
According to 22 analysts, Boston Scientific Corporation (NYSE:BSX)’s revenue estimates for the current quarter are $2.16B meanwhile the company has high revenue estimates of $2.19B in contradiction of low revenue estimates of $2.14B. For the current year the company’s revenue estimates are $8.36B compared to low analyst estimates of $8.34B and high estimates of $8.38B according to the projection of 25 analysts.